Skip to content Skip to footer
Menu Close
Close

Pharmbiotest Poland

Broadening Our Global Footprint with a Phase I Facility in Poland

Revival Site Network has entered a strategic partnership with Pharmbiotest Poland to expand its global clinical research footprint and strengthen early-phase trial capabilities.

Bed Clinical Unit

0

Principal Investigators

0+

Studies Yearly

0+

Therapeutic Areas

0+

Sites Across the US

0+

Partnership Overview

Through this partnership, Revival Site Network extends its ability to support sponsors and CROs with globally aligned research operations while maintaining consistent quality and compliance standards across regions.

Revival Site Network

A leading integrated research site network specializing in serving diverse patient populations and delivering clean, query-free data. Revival integrates cutting-edge technologies to reduce risks, minimize errors, and optimize trial processes for sponsors.

30+ Principal Investigators
25+ Sites
200+ Studies/Year
12+ Therapeutic Areas

Pharmbiotest Poland

Strategically based in Europe, Pharmbiotest specializes in generic and hybrid pharmaceutical product development, providing integrated R&D, clinical, and bioanalytical services. With strong technical expertise and European regulatory experience, they serve as a dependable partner for pharma and healthcare companies.

European Regulatory Experience
Full-Service R&D
GLP-Certified Lab
CTIS Submission

Revival Site Network

A leading integrated research site network specializing in serving diverse patient populations and delivering clean, query-free data. Revival integrates cutting-edge technologies to reduce risks, minimize errors, and optimize trial processes for sponsors.

30+ Principal Investigators
25+ Sites
200+ Studies/Year
12+ Therapeutic Areas

Pharmbiotest Poland

Strategically based in Europe, Pharmbiotest specializes in generic and hybrid pharmaceutical product development, providing integrated R&D, clinical, and bioanalytical services. With strong technical expertise and European regulatory experience, they serve as a dependable partner for pharma and healthcare companies.

European Regulatory Experience
Full-Service R&D
GLP-Certified Lab
CTIS Submission
Core Capabilities

End-to-End Clinical Research Services

The Poland facility offers comprehensive, full-service solutions from formulation development through regulatory submission as well as individual service modules tailored to sponsor needs.

R&D of Generic Drugs

Formulation development for generic and hybrid pharmaceutical products, including composition, dosage form selection, and production technology.

BA/BE Studies

Bioavailability and bioequivalence studies with full pharmacokinetic evaluation, statistical analysis, and final reporting compliant with EMA/FDA guidelines.

Phase I Clinical Trials

Full-service Phase I studies including FIH, SAD/MAD, dose escalation, drug-drug interaction, food-effect, and biosimilarity studies.

Clinical Trial Documentation

Study protocol, ICF, CRF, randomization, CTIS submission and progress maintenance, plus 25-year archiving of all study documents.

GLP-Certified Bioanalytical Services

LC/MS-MS method development and validation per M10 ICH guidelines, analysis of small molecules in human plasma and dried blood spots.

Biostatistics & Analysis

Statistical analysis plans, PK evaluation, pharmacokinetic and statistical reporting (BA/BE), and full study reporting with CTIS results publication.

Therapeutic Drug Monitoring

Analytical support in therapeutic drug monitoring and drug development consulting throughout the product lifecycle.

Quality Assurance

QA of study protocols, CRFs, subject documentation, analytical results, and reports with staff trained in GLP and certified in GCP.
Phase I Expertise

Types of Phase I Clinical Trials Conducted

The facility conducts the full spectrum of early-phase studies, offering both complete turnkey solutions and standalone service modules.

First-In-Human (FIH) Studies, Single-Ascending Dose (SAD) & Multiple-Ascending Dose (MAD)

Steady-State / Multi-Dose Drug Administration Studies

Bioavailability / Bioequivalence (BA/BE) Studies

Food-Effect Studies

Dose Escalation Studies

Drug-Drug Interaction Studies

Biosimilarity Studies

Infrastructure

State-of-the-Art Facility & Laboratory

The Poland facility is purpose-built for Phase I clinical research, with a fully equipped clinical unit and GLP-certified bioanalytical laboratory under one roof.

Clinical Department

Bioanalytical Laboratory

Why This Partnership

Our Key Advantages

What sets the Revival × Pharmbiotest Poland facility apart for sponsors and CROs?

Cardiovascular & Neurological Expertise

Deep experience developing drugs in these high-demand therapeutic areas.

Full Turnkey Phase I

Complete end-to-end solutions from study design to final report and CTIS submission.

30+ Successful Phase I Studies

Proven track record with a broad range of compounds and complex study designs.
Clinical Unit & GLP Lab Under One Roof

Integrated facility minimizes sample transfer risk and turnaround time.

Complex Study Designs

Experienced in full-replicate, two-stage, and other demanding BA/BE designs.

European Regulatory Alignment

CTIS-experienced team ensures smooth regulatory document submission and maintenance across EU markets.

Any Complexity of Bioanalytical Methods

From ultrahigh sensitivity pg/ml assays to chiral compounds and multi-matrix analyses.

GCP & GLP Certified Staff

All team members are trained and certified to international quality standards.

Advancing Medicine.
Across Borders.

Whether you’re a sponsor, physician, or potential participant, your next step in advancing healthcare begins with Revival.